Oppenheimer Asset Management’s Halozyme HALO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.91M	Buy	29,569 +316	+1%	+$22.3K	0.02%	566
2025 Q4	$1.97M	Sell	29,253 -1,861	-6%	-$125K	0.02%	504
2025 Q3	$2.28M	Sell	31,114 -9,381	-23%	-$623K	0.03%	532
2025 Q2	$2.11M	Sell	40,495 -1,318	-3%	-$75K	0.02%	536
2025 Q1	$2.67M	Sell	41,813 -15	-0%	-$871	0.03%	455
2024 Q4	$2M	Sell	41,828 -8,043	-16%	-$412K	0.02%	532
2024 Q3	$2.85M	Buy	49,871 +23,966	+93%	+$1.37M	0.03%	450
2024 Q2	$1.36M	Buy	25,905 +3,308	+15%	+$145K	0.02%	638
2024 Q1	$919K	Sell	22,597 -2,521	-10%	-$94.5K	0.01%	702
2023 Q4	$928K	Sell	25,118 -3,027	-11%	-$114K	0.01%	729
2023 Q3	$1.08M	Buy	28,145 +54	+0.2%	+$2.21K	0.02%	670
2023 Q2	$1.01M	Buy	28,091 +32	+0.1%	+$1.09K	0.01%	701
2023 Q1	$1.07M	Sell	28,059 -17,933	-39%	-$841K	0.02%	671
2022 Q4	$2.62M	Buy	45,992 +2,964	+7%	+$152K	0.04%	408
2022 Q3	$1.7M	Buy	43,028 +4,165	+11%	+$184K	0.03%	492
2022 Q2	$1.71M	Buy	38,863 +216	+0.6%	+$9.34K	0.03%	513
2022 Q1	$1.54M	Buy	38,647 +547	+1%	+$19.5K	0.02%	612
2021 Q4	$1.53M	Sell	38,100 -4,686	-11%	-$175K	0.02%	638
2021 Q3	$1.74M	Buy	42,786 +9,804	+30%	+$410K	0.02%	579
2021 Q2	$1.5M	Sell	32,982 -18	-0.1%	-$797	0.02%	628
2021 Q1	$1.38M	Buy	33,000 +10,109	+44%	+$462K	0.02%	626
2020 Q4	$978K	Buy	22,891 +385	+2%	+$13.8K	0.02%	687
2020 Q3	$592K	Buy	22,506 +646	+3%	+$18K	0.01%	771
2020 Q2	$586K	Buy	21,860 +18,451	+541%	+$416K	0.01%	752
2020 Q1	$61K	Buy	+3,409	New	+$64.7K	﹤0.01%	1222